Table 1.
Baseline characteristics.
Patients | n = 101 |
---|---|
Age | |
18–28 | 8 (7.9%) |
29–39 | 12 (11.9%) |
40–50 | 13 (12.9%) |
51–61 | 30 (29.7%) |
62–72 | 26 (25.7% |
73–83 | 12 (11.9%) |
Sex | |
Men | 44 (43.6%) |
Women | 57 (56.4% |
ECOG Score | |
≤1 | 101 (100%) |
Histological type | |
Liposarcoma | 14 (13.7%) |
Leiomyosarcoma | 26 (25.5%) |
Undifferentiated pleomorphic sarcoma | 9 (8.8%) |
Rhabdomyosarcoma | 7 (6.9%) |
Synovial sarcoma | 5 (4.9%) |
Clear cell sarcoma | 4 (3.9%) |
Pleomorphic sarcoma | 4 (3.9%) |
Myxofibrosarcoma | 4 (3.9%) |
Peripheral nerve sheath tumor | 3 (2.9%) |
Myxoid liposarcoma | 3 (2.9%) |
Carcinosarcoma | 2 (2.0%) |
Desmoplastic small round cell tumor | 2 (2.0%) |
NOS sarcoma | 2 (2.0%) |